Vor Biopharma Inc. (VOR): Submission of Matters to a Vote of Security Holders
Vor Biopharma Inc. (VOR) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. EX-10.1 2 vor-ex10_1.htm EX-10.1 EX-10.1 321452236 v8 Vor Biopharma Inc. Amended and Restated 2021 Equity Incentive Plan Adopted by the Board of Directors: April 16, 2026 Approved by the Stockholders: June 11, 2026 321452236 v8 Table of Contents Page 1. General. 1 2. Shares Subje
How this was made
The 30-second read
Why it matters
The key new information is stockholder approval of the amended plan, which governs future equity awards and share reserve capacity; the provided excerpt does not include any new clinical or financial guidance.
Market read
Primarily affects equity-compensation/dilution expectations rather than near-term business performance.
What to watch
Traders may focus on the plan’s share reserve mechanics (initial cap plus recurring increases) when assessing longer-term dilution, even if near-term fundamentals are unchanged.
Background
The 8-K Item 5.07 reports matters submitted to a vote of security holders, including approval of an amended and restated equity incentive plan.
Ticker impact
Vor Biopharma filed an 8-K disclosing stockholder approval of an amended and restated 2021 Equity Incentive Plan (approved June 11, 2026).
Likely limited/short-lived impact; any reaction would be more about dilution optics than new business fundamentals.
The filing is a corporate governance/compensation plan update with no new clinical, financial, or deal terms disclosed in the provided text.
Market effects
Routine equity incentive plan updates are common in biotech; no sector-wide signal is provided here.
None indicated.
None indicated.
Counterpoint
If the plan includes an automatic annual share reserve increase (4% for 10 years), the market could re-rate dilution risk more than expected even without operating news.
Key entities
- issuerVor Biopharma Inc.
Company filing the 8-K and whose stockholders approved the amended and restated equity incentive plan.
- corporate_actionAmended and Restated 2021 Equity Incentive Plan
Equity compensation plan approved by stockholders on June 11, 2026; includes a share reserve and annual increase mechanics described in the exhibit.
